833.3%. That was JBT Marel’s year-over-year jump in net income for the three months ended June 30, to $28 million from $3 million. The stock fell 8.2% at the latest close, to $122.02, but the stranger number is inside the income statement.
Revenue rose 4.9% to $981 million. Operating income went the other way, slipping from $48 million to $46 million, which pulled the operating margin down to 4.7% from 5.1%. The business sold more and kept slightly less at the operating level; the eye-catching profit increase arrived after that line.
The comparison starts from an unusually small base, but the filing also gives the mechanics. Management points to lower acquisition-related depreciation and amortization, lower interest expense, and a favorable net tariff impact. Those helped offset a $33 million intangible-asset impairment charge and higher inflationary costs.
"The increase was primarily driven by higher revenue, lower acquisition-related depreciation and amortization expense, lower interest expense, and a favorable net tariff impact, partially offset by a $33 million intangible asset impairment charge recorded during the second quarter of 2026 and higher inflationary costs."
JBT Marel, Form 10-Q, Aug. 5, 2026
That is a busy list for a $25 million increase in net income. It includes a lower financing cost, a tariff effect that management calls favorable in one passage, and a large impairment charge that belongs in operating results. The filing does not reduce the profit jump to one clean operating driver.
The company’s adjusted profitability had a more ordinary shape. Management said higher sales volume and fixed-cost leverage helped adjusted EBITDA, while inflation and net tariff costs remained headwinds.
"The increases in Adjusted EBITDA and Adjusted EBITDA margin were primarily driven by higher sales volume and improved leverage of fixed costs compared to the prior-year period, partially offset by higher inflationary costs and net tariff costs, inclusive of tariff recoveries recognized during the second quarter of 2026, which remained a headwind during the period."
JBT Marel, Form 10-Q, Aug. 5, 2026
So the filing contains two different kinds of progress. Volume and fixed-cost leverage supported the adjusted measure. Reported operating income still declined, with the margin narrowing despite the revenue increase. Tariff recoveries helped, but the company also says net tariff costs remained a headwind. The wording leaves the benefit and burden in the same quarter, because apparently tariffs wanted both a credit and a speaking role.
The balance-sheet numbers add another layer. Inventory rose 5.9% to $700 million, faster than revenue, while accounts receivable increased 7.1% to $443 million. Capex was up 30.8% year over year. None of those movements is given a specific cause in the filing, but they make the sales increase more consequential for cash conversion than the income statement alone suggests.
JBT Marel’s recent annual history supplies context without resolving the point. Revenue reached $3.8B in 2025 after rising 121.3%, but annual operating margin was 5.0% and net margin was negative 1.3%. The latest three months show revenue growth continuing, while operating profitability remains close to that recent annual level.
At $6.3B of market capitalization and $7.6B of enterprise value, the company carries $1.3B of net debt. Its enterprise-value-to-sales ratio is 2.0x. Those figures frame the question, rather than answer it: how much of the business’s earnings power is coming from repeatable volume and cost leverage, and how much from financing, impairment, and tariff accounting in this particular period?
JBT Marel’s next quarterly report will have one especially useful comparison to make: whether operating margin and the inventory and receivables build move in the same direction after this three-month result. Is the 833.3% profit jump becoming an operating trend, or is it still mostly a below-the-line event?
Source: JBT Marel Corporation Form 10-Q filed Aug. 5, 2026.